Abstract: This review reports details on the natural products isolated from Taiwan soft corals during the period 2008-2012 focusing on their in vitro and/or in vivo anti-inflammatory activities. Chemical structures, names, and literature references are also reported. This review provides useful and specific information on potent anti-inflammatory marine metabolites for future development of immune-modulatory therapeutics.
Introduction
Marine natural products, especially those from stationary or slow moving marine organisms, are used naturally as a chemical defense to protect the organisms from dangerous predators, stressful local environments, and/or the encroachment of competitors. Due to the biological and chemical diversity of marine habitats, and the identification and greater understanding of marine secondary metabolites with unique chemical structures and biological activities, natural products from marine organisms are increasingly being considered as a major source of new therapeutics [1] [2] [3] . More than 20,000 novel compounds have been isolated and identified from marine organisms since the 1960s [4] . At least two current drugs and a series of anti-tumor drug candidates in preclinical or clinical trials have been developed from marine natural products [2] [3] [4] . The soft corals or Alcyonacea, an order of Anthozoa widely distributed in warm seawaters, have been a particular focus of attention. An abundance of unique secondary metabolites including sesquiterpenoids, diterpenoids, steroids and other chemical compounds have been isolated and identified from various species of soft corals [5] [6] [7] . It has been estimated that the percentage of new metabolites discovered from soft corals represents up to 22% of the total new marine natural products reported from 2010 to 2011 [5, 6] . Importantly, many of the natural products discovered from soft corals have been demonstrated to exhibit a spectrum of biological activities such as anti-tumor, antiviral, antifouling and anti-inflammatory [5] [6] [7] [8] .
Inflammation processes often constitute an initial activation of the mammalian immune system, and the body's normal defense or protective mechanisms in response to microbial infection or irritation or injury of tissues/organs. Increasing evidence suggests a critical link between inflammation and the chronic promotion/progression of various human diseases, including atherosclerosis, diabetes, arthritis, inflammatory bowel disease, cancer and Alzheimer. Proinflammatory enzymes, particularly the inducible nitric oxide synthase (iNOS) for nitric oxide production and cyclooxygenase (COX-2) for prostaglandin production, have been demonstrated to play central roles in the development of inflammatory diseases. In addition, it is also known that during the initial phase of acute inflammation, neutrophils are one of the first leukocyte populations to migrate towards the damaged tissue sites [9] . Neutrophils play a key role in the pathogenesis of various chronic inflammation diseases such as rheumatoid arthritis [10, 11] . Activated neutrophils can secrete the superoxide anion, reactive oxygen species (ROS) and enzymes that are associated with the killing of invading pathogens [12] . Furthermore, elastase secreted by stimulated neutrophils has been recognized to play a key contribution in the demolition of tissues affected by chronic inflammatory disease [13] . Therefore, evaluation of the inhibition of iNOS and COX-2 expression, the production of superoxide anion, and the release of elastase in inflammatory cells/tissues by various natural products have been extensively employed in a spectrum of in vitro preliminary screening systems for lead compound or drug discovery. Recently, a number of marine biology and chemistry researchers in Taiwan (including our laboratory) have systematically screened several marine natural products isolated from soft corals for such in vitro anti-inflammatory activities, mainly by measuring the inhibition of iNOS, COX-2, superoxide anion or elastase in murine immune cells. Animal models were further used to evaluate the potential therapeutic activities of candidate compounds in specific disease models. This report reviews some recent representative studies and examples of marine natural products with anti-inflammatory and other related bioactivities that have been isolated from soft corals of Taiwan. Soft corals are abundant in the off-shore environment of the island of Taiwan, and have hence become a focus of local studies of marine nature products. We hope that this review will provide a useful data for the further study of marine natural products.
Results and Discussion
In the reports reviewed here, anti-inflammatory activities of natural products from the soft corals of Taiwan were generally determined in vitro by their inhibition of LPS-induced expression of iNOS and COX-2 in murine macrophage cells (RAW264.7) or by their inhibition of the production of superoxide anion and the release on the elastase from human neutrophils in response to FMLP/CB.
Sesquiterpenoids
2.1.1. Triquinane-Type Sesquiterpenoids Table 1 Figure 2 . Figure 3 . Table 5 summarizes three ylangene-type sesquiterpenoids (27) (28) (29) Figure 6 . Figure 7 . 
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At a concentration of 10 µM, compounds 1-3, 13, 24, 28, 33 and 34 reduced LPS-induced expression of iNOS in murine macrophage cells [14] [15] [16] 18, 21, 22] . Compounds 1, 2, 13, 17, 18, 21 and 28 suppressed LPS-induced expression of COX-2 in these cells [14] [15] [16] [17] . At 10 µg/mL, compound 38 was shown to slightly inhibit the generation of superoxide anion in FMLP/CB-stimulated human neutrophils, and compound 31 weakly inhibited the release of elastase by activated human neutrophils [19, 24] . In addition, an inflammation animal model induced by intraplantar injection of carrageenan into rat hind paws was also used to evaluate in vivo anti-inflammatory activity of lemnalol (28) . Intramuscular injection of 28 (15 mg/kg) significantly inhibited the carrageenan-induced rat paw edema and thermal hyperalgesia behavior. Moreover, lemnalol significantly suppressed the carrageenan-induced expression of iNOS and COX-2 in paw tissue of test rats. Post-intrathecal injection of lemnalol provided an antinociceptive effect in carrageenan-injected rats (1 and 5 μg) [25] . Δ 9(12) -capnellene-8β,10α-diol (GB9, 1) and its acetylated derivative, 8α-acetoxy-Δ 9(12) -capnellene-10α-ol (GB10, 2) were reported to inhibit the expression of iNOS and COX-2 in BV2 cells post-stimulation by IFN-γ.
Intraperitoneal administration of GB9 reduced CCI-induced thermal hyperalgesia, suppressed microglial cells activation and COX-2 upregulation in the dorsal horn of the lumbar spinal cord, ipsilateral to the injury. Also, intrathecal administration of GB9 and GB10 suppressed activities of CCl-induced nociceptive sensitization and thermal hyperalgesia [26] . The above findings suggest that some of these compounds may warrant systematic investigation for future development as immune-modifiers. Table 8 * Inhibition of iNOS (I), COX-2 (C), superoxide anion (S) and elastase (E). [27, 29, [31] [32] [33] [34] [35] [36] [37] 39, 41] . At 10 µg/mL, compound 126 inhibited the generation of superoxide anion and the release of elastase in human neutrophils [44] . Compound 130 inhibited the release of elastase by activated human neutrophils [24] . For in vivo anti-inflammatory activities, subcutaneous (s.c.) administration of sinularin (90) (80 mg/kg) significantly inhibited carrageenan-induced nociceptive behaviors as well as carrageenan-induced activation of microglial and astrocyte, and the iNOS expression in the dorsal horn of the lumbar spinal cord [45] . Due to its promising anti-inflammatory profile, sinularin may warrant future exploration as a lead compound for immune-/inflammation-modulation. Table 12 Asterolaurin F Asterospicularia laurae [69] * Inhibition of superoxide anion (S) and elastase (E). * Inhibition of COX-2 (C), superoxide anion (S) and elastase (E). 131, 133, 134, 139, 140-143, 147, 148, 151-153,  157-160, 162-168, 170 ceramide and cerebrosides 174, 225, 229, 230, 235, 236, 239-242, 244, 245 , 258 and 259 reduced LPS-induced expression of iNOS in murine macrophage cells [46] [47] [48] [49] [50] [51] 66, 68, 70] . Compounds 134, 148, 151, 160, 163, 164, 166-168, 225, 258 and 259 suppressed the LPS-induced expression of COX-2 in these cells [46] [47] [48] [49] [50] 66, 70] . At 10 µg/ mL, compounds 180, 184, 186, 188,  198-205, 208-210, 213, 216, 217, 222, 232, 233, 255 and 261 inhibited the generation of superoxide anion by activated human neutrophils [54-56,58-65,67,69,70,72]. Compounds 180, 184, 186, 188, 202-204, 207, 210, 212, 213, 215-217, 222, 232, 233, 255, 260 and 261 inhibited the release of elastase from these activated human neutrophils [53] [54] [55] [56] 59, 61, 63, 65, 67, 69, 71, 72] . These results provided useful baseline information on the immune-regulatory and anti-oxidant activities of various marine diterpenoids. Compound 184, as 185 epimer at C-6, was showed to be more potent in the inhibition of the generation of superoxide anion and in inducing the release of elastase by active human neutrophils, suggesting that the stereochemistry at C-6 may play a key role in the above biological effects [54] .
Diterpenoids

Cembrane-Based Diterpenoids
Eunicellin-Based Diterpenoids
Norditerpenoids
The briarane-type diterpenoid excavatolide B (189) has been demonstrated to significantly inhibit TPA-induced cutaneous inflammation activities in mice, including those related to vascular permeability, edema, and TPA-induced expression of iNOS, COX-2 and matrixmetalloproteinase-9. Excavatolide B also suppressed LPS-induced expression of TNF-α and IL-6 in mouse bone marrow derived dendritic cells (BMDCs) [57] . Also, excavatolide F (191), K (190) and Z (193) and briaexcavatolide B (194), H (196), K (195) and R (192) exhibited a broad spectrum of activity in inhibition of LPS-induced expression of IL-6 in BMDCs [57] . A study on the structure-activity relationship between the structures of the briarane-type diterpenoids and their inhibition of IL-6 expression in BMDCs revealed that the eight 17-epoxide of briarane-type diterpenoids may play an important role in the inhibition of IL-6 expression in specific immune cells [57] . Replacement of the C-12 hydroxyl group with long esters in briarane-type diterpenoids decreased the inhibition of IL-6 expression [57] . Table 15 [21, [74] [75] [76] [77] [78] [79] [80] 84] . At 10 µg/mL, compounds 321 and 322 inhibited the generation of superoxide anion and the release of elastase by activated human neutrophils [73, 85] . Figure 16 . Figure 17 . 
Steroids
Ceramide and Cerebrosides
339
At a concentration of 10 µM, compounds 323, 324, 326-330, 334, 335 and 339 reduced LPS-induced expression level of iNOS in murine macrophage cells (RAW264.7) [86] [87] [88] . Compounds 323, 334 and 339 suppressed LPS-induced expression levels of COX-2 in murine macrophage cells (RAW264.7) [86, 88] . Austrasulfone (338) was found to exhibit a potent neuroprotective effect in human dopaminergic neuron cells (SH-SY5Y) [89, 90] . In animal disease models, the synthetic precursor of austrasulfone dihydroaustrasulfone alcohol (339) was not only demonstrated to attenuate neuropathic pain, but also to suppress the progression of multiple sclerosis and atherosclerosis [88] .
Conclusions
Marine invertebrates, particularly octocorals, are rich potential sources of drug leads. Most of our own and other studies on anti-inflammatory activities of natural products from soft corals have been focused on "screening-like" assays using COX-2 and iNOS as target markers. These assay studies have been useful in generating small libraries of anti-oxidant and anti-inflammatory activities from a broad spectrum of soft corals. These results, however, apparently have limitations. For example, the findings are usually generic in nature, and there is often difficulty in immediate or specific application of such results to drug/pharmaceutical discovery, as compared to the existing synthetic chemicals or phytochemicals or those being developed for clinical use. We [45, 57, 88] and others [25, 26] have recently initiated a number of cross-disciplinary studies, employing bio-organic chemistry, cellular immunology and animal disease models for systematic and in-depth studies. As a result, we believe that useful information on the possible application of specific natural products from soft corals for future clinical studies have been obtained. We consider such approaches [57] may need to be encouraged and organized at the international level, and hopefully be integrated into systematic studies, aiming to create translational research of marine natural products for pharmaceuticals/nutraceuticals. Special emphasis may need to be placed on new or specific cell biological/disease model systems.
In terms of evaluating marine natural products for future pharmaceutical application, despite the abundance of unique marine natural products identified, the extremely low quantity of a given compound of interest that can be isolated from marine organisms may be a big hurdle for evaluation of in vivo bioactivities and development for pharmaceutical applications.
Fortunately, due to the recent advancement in aquaculture technologies, aquacultural cultivation of various types of specific soft corals is becoming possible. Our team has successfully cultured a number of species of soft corals, including Klyxum simplex and Briareum excavatum [47, 91] . As a result, more abundant and routine preparations of experimental materials will become available for global distribution and collaborative research purposes. Nonetheless, the vast volume of marine organisms and the small base of knowledge so far assembled on soft coral-derived marine chemicals calls for increased international cooperation in this field.
